Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 11
Submit an article Journal homepage
62
Views
12
CrossRef citations to date
0
Altmetric
Letters to the Editor

The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy

Yu-Feng LiDepartment of Hematology, No. 1 Hospital of Huaian affiliated to Nanjing Medical University, Huaian, Jiangsu, ChinaCorrespondence[email protected]
,
Xiaolin LiuDepartment of Hematology, No. 1 Hospital of Huaian affiliated to Nanjing Medical University, Huaian, Jiangsu, China
,
Ding-Shen LiuDepartment of Hematology, No. 1 Hospital of Huaian affiliated to Nanjing Medical University, Huaian, Jiangsu, China
,
Ban-He DinDepartment of Hematology, No. 1 Hospital of Huaian affiliated to Nanjing Medical University, Huaian, Jiangsu, China
&
Jian-Bin ZhuDepartment of Hematology, No. 1 Hospital of Huaian affiliated to Nanjing Medical University, Huaian, Jiangsu, China
Pages 1889-1891 | Received 16 Jun 2009, Accepted 27 Jul 2009, Published online: 08 Oct 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Yaoyu Chen & Shaoguang Li. (2014) Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia. OncoTargets and Therapy 7, pages 177-186.
Read now
Omar Al Ustwani, Elizabeth A Griffiths, Eunice S Wang & Meir Wetzler. (2014) Omacetaxine mepesuccinate in chronic myeloid leukemia. Expert Opinion on Pharmacotherapy 15:16, pages 2397-2405.
Read now
Aziz Nazha, Hagop Kantarjian, Jorge Cortes & Alfonso Quintás-Cardama. (2013) Omacetaxine mepesuccinate (synribo) – newly launched in chronic myeloid leukemia. Expert Opinion on Pharmacotherapy 14:14, pages 1977-1986.
Read now
Jiabing Zhu, Banhe Ding & Yufeng Li. (2013) Long-term effect of interferon-α combined with homoharringtonine on chronic myelogenous leukemia in chronic phase. Leukemia & Lymphoma 54:7, pages 1426-1429.
Read now
Yu-Feng Li, Zhikui Deng, Ban-He Din & Jian-Bin Zhu. (2012) Effect of homoharringtonine on bone marrow CD34 + CD117 + cells in patients with chronic myelogenous leukemia. Leukemia & Lymphoma 53:5, pages 934-939.
Read now
Theo Daniel Kim, Mareike Frick & Philipp le Coutre. (2011) Omacetaxine mepesuccinate for the treatment of leukemia. Expert Opinion on Pharmacotherapy 12:15, pages 2381-2392.
Read now

Articles from other publishers (6)

Kodappully S. Siveen, Kirti S. Prabhu, Iman W. Achkar, Shilpa Kuttikrishnan, Sunitha Shyam, Abdul Q. Khan, Maysaloun Merhi, Said Dermime & Shahab Uddin. (2018) Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products. Molecular Cancer 17:1.
Crossref
Joëlle Pérard-Viret, Laith Quteishat, Rana Alsalim, Jacques Royer & Françoise Dumas. 2017. 205 352 .
Lina Zhang, Zhenzhu Chen, Wenli Zuo, Xinghu Zhu, Yufu Li, Xinjian Liu & Xudong Wei. (2016) Omacetaxine mepesuccinate induces apoptosis and cell cycle arrest, promotes cell differentiation, and reduces telomerase activity in diffuse large B‑cell lymphoma cells. Molecular Medicine Reports.
Crossref
Zhikui Deng, Yuanyuan Li & Yu-feng Li. (2015) Immunological Status of Chronic Myelogenous Leukemia Patients with Complete Cytogenetic Response after Treatment. Tumori Journal 101:3, pages 323-327.
Crossref
Yuanyuan Li, Zhikui Deng, Jiabin Zhu, Banhe Ding, Yuye Shi & Yufeng Li. (2014) Homoharringtonine Combined with Cytarabine to Treat Chronic Myelogenous Leukemia in Myeloid Blast Crisis and Its Impact on Bone Marrow CD34+CD7+ Cells. Acta Haematologica 132:2, pages 172-176.
Crossref
Yufeng Li, Jiabin Zhu & Banghe Ding. (2012) Homoharringtonine is an effective therapy for patients with polycythemia vera or essential thrombocythemia who have failed or were intolerant to hydroxycarbamide or interferon-α therapy. International Journal of Clinical Oncology 18:5, pages 922-926.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.